Home › Autoimmune Diseases › Maryland
Autoimmune Diseases clinical trials in Maryland
21 studies for Autoimmune Diseases are looking for participants at sites in Maryland.
Cities in Maryland
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT00867269NIAID Centralized Sequencing Protocol
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
1 Day – 100 Years · All sexes · Updated Oct 2, 2026 · NCT03206099Natural History of Bronchiectasis
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 5 to 100 · All sexes · Updated Oct 2, 2026 · NCT00943514Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 4 to 69 · All sexes · Updated Sep 28, 2026 · NCT04339777Environmental Risk Factors for the Anti-synthetase Syndrome
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 · All sexes · Updated Sep 28, 2026 · NCT01276470Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2Healthy volunteers welcome
Ages 4 to 75 · All sexes · Updated Sep 28, 2026 · NCT02579967Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 28, 2026 · NCT04097561Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Up to age 99 · All sexes · Updated Sep 24, 2026 · NCT00001350Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
1 Month – 100 Years · All sexes · Updated Sep 24, 2026 · NCT00246857Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- National Naval Medical Center, Bethesda
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Sep 22, 2026 · NCT00977977A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- American Oncology Partners of Maryland, PA, Bethesda
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
RecruitingPhase 2/3
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Johns Hopkins Hospital: Division of Rheumatology, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07103746Daratumumab in Primary Antiphospholipid Syndrome
- Johns Hopkins University, Baltimore
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 16, 2026 · NCT05671757A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
- The Johns Hopkins Hospital, Baltimore
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07182227A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 10, 2026 · NCT05027945A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 3 to 99 · All sexes · Updated Mar 9, 2026 · NCT04304820X-linked Moesin Associated Immunodeficiency
- National Institutes of Health, Bethesda
RecruitingObservational study
Ages 4 to 80 · Men · Updated Apr 25, 2025 · NCT06278337From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.